Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COVID-RASi Trial: ACEi/ARB in High-risk COVID-19 Patients
NCT04591210Phase 3Completed
- Sponsor
- University of Ottawa Heart Institute
- Start
- Jan 2021
- Primary completion
- Dec 2024
- Countries
- 3
01
Overview
Phase 3, randomised, open-label trial in coronavirus disease 2019 (COVID-19), sponsored by University of Ottawa Heart Institute. Started Jan 2021; status: completed.
02
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04591210.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04591210.